Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zenon Gibas is active.

Publication


Featured researches published by Zenon Gibas.


Cancer Genetics and Cytogenetics | 1986

A possible specific chromosome change in transitional cell carcinoma of the bladder

Zenon Gibas; George R. Prout; J. Edson Pontes; John G. Connolly; Avery A. Sandberg

Chromosome changes were ascertained in nine tumor samples from seven untreated patients with transitional cell carcinoma of the urinary bladder. All tumors analyzed showed abnormal karyotypes. In one tumor, a single numerical abnormality (+7) was the sole detectable change. From 1 to 19 structurally abnormal chromosomes could be identified in the remaining 8 tumors. The same abnormality, an isochromosome of the short arm of chromosome #5, was found in five tumors from four patients. We have previously described the presence of this marker chromosome in three of nine cases of transitional cell carcinoma of the bladder. We therefore conclude that i(5p) constitutes the most consistent nonrandom chromosome abnormality in this malignancy. Other chromosomes most frequently involved in structural changes in the present series of tumors were chromosomes #1, #6, #11, and #13.


Cancer Genetics and Cytogenetics | 1986

Chromosome changes in malignant mesothelioma

Zenon Gibas; Frederick P. Li; Karen H. Antman; Samuel D. Bernal; Rolf A. Stahel; Avery A. Sandberg

Cytogenetic study was made of mesothelioma cells from 14 patients. Metaphases were obtained from 12 tumors and revealed aneuploidy and clonal abnormalities in 9 specimens. In the two remaining cases, no metaphases were obtained. The cytogenetic abnormalities were complex, and up to 12 marker chromosomes were observed in the tumors. Rearrangements of chromosomes #1, #2, #3, #6, #9, #11, #17, and #22 were most frequently observed. Chromosome markers involved diverse bands, including several that are loci of oncogenes, fragile sites, and nonrandom rearrangements in other types of cancer. This study shows that the karyotypes of malignant mesothelioma can be analyzed by standard cytogenetic techniques. Additional studies of untreated mesothelioma may help to distinguish primary cytogenetic changes from effects of prior therapy in some of our patients.


Cancer Genetics and Cytogenetics | 1986

Chromosome changes in germ cell tumors of the testis

Zenon Gibas; George R. Prout; J. Edson Pontes; Avery A. Sandberg

Chromosome analysis was performed on short-term cultures established from samples of six tumors of the testis. Histologically, four tumors were embryonal cell carcinomas (three primary, one metastatic) and two of mixed histology with predominance of teratoma. The modal chromosome number was hypotriploid in four tumors, triploid in one, and hypertriploid in another. All tumors contained structurally abnormal chromosomes, ranging in number from 1 to 10 in different cases. A small metacentric marker chromosome, identified as an isochromosome of the short arm of chromosome #12 [i(12p)], was present in all tumors analyzed. Unlike other marker chromosomes, this one was invariably present in at least two copies per metaphase in all cases; all other chromosome markers were present in single copy in all tumors. Together with the previous reports on the presence of i(12p) in seminoma and teratoma of the testis, our findings suggest that this karyotypic abnormality is characteristic for all histologic varieties of germ cell tumors of the testis.


Cancer Genetics and Cytogenetics | 1984

A high-resolution study of chromosome changes in a human prostatic carcinoma cell line (LNCaP)

Zenon Gibas; Reinhard Becher; Elizabeth Kawinski; Julius Horoszewicz; Avery A. Sandberg

A high-resolution study of chromosomal rearrangements in a human prostatic cancer cell line, LNCaP, has been performed. The cytogenetic analysis revealed a pseudodiploid karyotype and the presence of seven marker chromosomes resulting from five aberrational events. The analysis of four clones derived from the original line showed a near-tetraploid chromosome number and the presence of the same seven markers observed in the original line. This is the first complete description of karyotypic rearrangements in a prostatic cancer cell line.


Cancer Genetics and Cytogenetics | 1988

Clonal chromosome rearrangements in a uterine myoma

Zenon Gibas; Constance A. Griffin; Beverly S. Emanuel

A cytogenetic study of a myoma of uterus with extensive hyaline, myxoid, and cystic degeneration revealed a clonal karyotype with a complex structural rearrangement involving chromosomes #3, #12, #14, #17, and #22. The modal chromosome number of the tumor was 45 due to monosomy #22. Analysis of seven additional myomas of the uterus including five tumors with typical histology and two with degenerative changes showed no clonal abnormalities. Single metaphases with a trisomy and a translocation were detected in two tumors. We conclude that although many uterine myomas appear to have normal karyotypes, clonal chromosome abnormalities are present in some of these tumors.


Cancer Genetics and Cytogenetics | 1983

Involvement of chromosomes 7 and 12 in large bowel cancer: trisomy 7 and 12q-.

Reinhard Becher; Zenon Gibas; Avery A. Sandberg

Cytogenetic analysis of an adenocarcinoma of the large bowel with some villous features revealed consistent chromosome changes: trisomy of chromosomes No. 7, 12, and 20 and a deletion of part of the long arm of a chromosome No. 12. Examination of the chromosome findings in previously published cases of large bowel cancers and the data presented in this paper lead us to suggest that trisomy No. 7 and 12q- may be nonrandom (primary) karyotypic changes in a subgroup of large bowel cancers.


Cancer Genetics and Cytogenetics | 1986

Chromosome abnormalities in two benign adipose tumors

Avery A. Sandberg; Zenon Gibas; Elizabeth Saren; Frederick P. Li; Janusz Limon; Cameron K. Tebbi

Two histologically benign adipose tumors were found to have clonal karyotypic changes. Del(4), del(6), and inv(13) were present in a fibrolipoma, and t(7;8) in a lipoblastoma. Additional studies are needed of the frequency and malignant potential of lipomas with cytogenetic abnormalities.


Cancer Genetics and Cytogenetics | 1983

Chromosome 6 in malignant melanoma

Reinhard Becher; Zenon Gibas; Avery A. Sandberg

Cytogenetic analysis of malignant melanoma (MM) cells from a number of cases revealed the frequent involvement of chromosome 6 in structural aberrations. The relevance of these findings to certain aspects of MM is briefly discussed.


Cancer Genetics and Cytogenetics | 1986

Methodologic advances in the cytogenetic analysis of human solid tumors

Jeffrey M. Trent; Kent Crickard; Zenon Gibas; Angela Goodacre; Sen Pathak; Avery A. Sandberg; Floyd H. Thompson; Jacqueline Whang-Peng; Sandra R. Wolman

The major obstacle to successful cytogenetic analysis of human solid tumors is the acquisition of sufficient numbers of good quality metaphases for detailed cytogenetic analysis. At present, no single methodologic approach has been proven to provide successful chromosomal analysis of all human solid tumors. The technical aspects of cell culture, chromosome harvesting, and chromosome banding were the focus of considerable discussion during the First Workshop on Chromosomes in Solid Tumors. This report provides summaries of several technical protocols, emanating from several different laboratories, which have contributed to successful chromosome analysis of a variety of human solid tumors.


Cancer Genetics and Cytogenetics | 1985

Chromosome rearrangements in a metastatic adenocarcinoma of the prostate

Zenon Gibas; J. Edson Pontes; Avery A. Sandberg

Cytogenetic analysis of a metastatic tumor derived from an adenocarcinoma of the prostate revealed a hypodiploid karyotype with the presence of six marker chromosomes. The findings are discussed in relation to cytogenetic findings in other cancers, including those in prostatic cancer.

Collaboration


Dive into the Zenon Gibas's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Reinhard Becher

University of Duisburg-Essen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Beverly S. Emanuel

Children's Hospital of Philadelphia

View shared research outputs
Top Co-Authors

Avatar

Constance A. Griffin

Children's Hospital of Philadelphia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hisako Ochi

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Longina M. Gibas

Thomas Jefferson University

View shared research outputs
Researchain Logo
Decentralizing Knowledge